Urol. praxi, 2014; 15(1): 22-25

Bone densitometry in urological practice

MUDr.Petr Kasalický
Osteocentrum Mediscan Praha

Bone densitometry is an essential method for assessing the risk of fractures, diagnosing osteoporosis and even reimbursing the treatment

of osteoporosis (primary as well as secondary one). DXA (dual-energy x-ray absorptiometry) is currently the fundamental densitometric

technique. In addition to commonly assessed values (BMD – bone mineral density), there are other parameters that can be obtained by

bone densitometry. Indications to bone densitometry are primarily in the hands of specialists concerned with diagnosing and treating

osteoporosis. However, this methodology can also be utilized by urologists in their practice, particularly in cases of secondary osteoporosis

in hypogonadism, in primary hyperparathyroidism and/or in the differential diagnosis of vertebral body compression. DXA densitometry

is one of the methods required in some clinical evaluations in urology, affecting possible classification of patients; therefore, it

should be available for urological practices. Ideally, there should be good interdisciplinary collaboration among the urologist, the bone

densitometry unit as well as outpatient departments and specialists who deal with metabolic bone diseases.

Keywords: fracture risk, osteoporosis, bone densitometry

Published: February 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kasalický P. Bone densitometry in urological practice. Urol. praxi. 2014;15(1):22-25.
Download citation

References

  1. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 1994; 843: 785-795.
  2. Kanis JA. The diagnosis of osteoporosis. J Bone Miner Res 1997; 9(8): 1137-1141. Go to original source... Go to PubMed...
  3. NIH Consens Statement. Osteoporosis Prevention, Diagnosis, and Therapy. 2000; 17(1): 1-36.
  4. ##
  5. Wei JT, Gross M, Jaffe CA, et al. Androgen deprivation therapy for prostate cancer results in significant loss of bone density. Urology 1999; 54: 607-611. Go to original source...
  6. Conde FA, Sarna L, Oka RK, et al. Age, body mass index, and serum prostate specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy. Urology 2004; 64: 335-340. Go to original source...
  7. Shahinian VB, Kuo YF, Freeman JL, et al. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005; 352: 154-164. Go to original source... Go to PubMed...
  8. Melton LJ, Aalothman KL, Khosia S, et al. Fracture risk following bilateral orchiectomy. J Urol 2003; 169: 1747-1750. Go to original source...
  9. Michaelson MD, Cotter SE, Gargollo PC, et al. Management of complications of prostate cancer treatment. Ca Cancer J Clin 2008; 58: 196-213. Go to original source... Go to PubMed...
  10. Bae DC, Stein BS. The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate. J Urol 2004; 172: 2137-2144. Go to original source...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.